Nissay Asset Management Corp Japan ADV increased its holdings in shares of Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 10.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 306,660 shares of the company's stock after acquiring an additional 30,006 shares during the period. Nissay Asset Management Corp Japan ADV's holdings in Keurig Dr Pepper were worth $10,494,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently bought and sold shares of KDP. Vanguard Group Inc. grew its holdings in Keurig Dr Pepper by 21.3% during the first quarter. Vanguard Group Inc. now owns 145,012,806 shares of the company's stock worth $4,962,338,000 after acquiring an additional 25,425,644 shares during the period. JPMorgan Chase & Co. grew its holdings in Keurig Dr Pepper by 108.1% during the first quarter. JPMorgan Chase & Co. now owns 38,882,672 shares of the company's stock worth $1,330,565,000 after acquiring an additional 20,196,835 shares during the period. T. Rowe Price Investment Management Inc. grew its holdings in Keurig Dr Pepper by 981.3% during the first quarter. T. Rowe Price Investment Management Inc. now owns 2,514,608 shares of the company's stock worth $86,050,000 after acquiring an additional 2,282,050 shares during the period. Seven Grand Managers LLC acquired a new position in Keurig Dr Pepper during the first quarter worth $51,330,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Keurig Dr Pepper by 15.7% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 9,260,957 shares of the company's stock valued at $297,462,000 after purchasing an additional 1,258,062 shares in the last quarter. Institutional investors and hedge funds own 93.99% of the company's stock.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on KDP. HSBC reaffirmed a "hold" rating and issued a $30.00 price objective (down from $42.00) on shares of Keurig Dr Pepper in a research note on Tuesday, August 26th. Deutsche Bank Aktiengesellschaft dropped their price objective on Keurig Dr Pepper from $40.00 to $38.00 and set a "buy" rating for the company in a research note on Tuesday, August 26th. UBS Group dropped their price objective on Keurig Dr Pepper from $40.00 to $35.00 and set a "buy" rating for the company in a research note on Wednesday, August 27th. Barclays raised their price objective on Keurig Dr Pepper from $37.00 to $39.00 and gave the company an "overweight" rating in a research note on Monday, July 28th. Finally, JPMorgan Chase & Co. dropped their price objective on Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating for the company in a research note on Thursday, July 17th. Eleven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $38.38.
View Our Latest Research Report on KDP
Keurig Dr Pepper Trading Down 3.6%
Shares of NASDAQ:KDP traded down $1.02 during midday trading on Monday, reaching $27.63. The company's stock had a trading volume of 34,799,511 shares, compared to its average volume of 19,150,458. The firm has a market cap of $37.53 billion, a price-to-earnings ratio of 24.67, a price-to-earnings-growth ratio of 1.57 and a beta of 0.47. The company has a quick ratio of 0.40, a current ratio of 0.64 and a debt-to-equity ratio of 0.56. Keurig Dr Pepper, Inc has a 1 year low of $27.24 and a 1 year high of $38.28. The business has a 50 day moving average price of $32.83 and a 200 day moving average price of $33.45.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last announced its quarterly earnings data on Thursday, July 24th. The company reported $0.49 EPS for the quarter, meeting analysts' consensus estimates of $0.49. The business had revenue of $4.16 billion during the quarter, compared to the consensus estimate of $4.14 billion. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.The business's revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.45 earnings per share. Research analysts forecast that Keurig Dr Pepper, Inc will post 1.92 EPS for the current year.
Insiders Place Their Bets
In other news, insider Mary Beth Denooyer sold 12,000 shares of Keurig Dr Pepper stock in a transaction on Thursday, July 17th. The stock was sold at an average price of $33.66, for a total value of $403,920.00. Following the completion of the sale, the insider owned 82,511 shares of the company's stock, valued at $2,777,320.26. The trade was a 12.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert James Gamgort sold 7,601 shares of Keurig Dr Pepper stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $35.91, for a total value of $272,951.91. Following the completion of the sale, the director directly owned 2,284,568 shares of the company's stock, valued at approximately $82,038,836.88. This represents a 0.33% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 459,601 shares of company stock valued at $15,228,872. Company insiders own 1.00% of the company's stock.
Keurig Dr Pepper Company Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
See Also

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report